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• Novel Contrast Agent Targeted to Ultrasonic 
D-Dlmer Using DD-3B6 Monoclonal F(ab) In Vitro 
Gregory M. Lanza, Kirk D. Wallace, Paul R. Eisenberg, Michael J. Scott, 
William P. Cscherls, Donald H. Christy, Angola M. Sharkey, James G. Miller, 
Samuel A. Widdine. JeR~sh And Barnes Hospi;als M Washington University, 
St. Louis, MO 
To facilitate sensitive and specific detection of vascular thromboses, we have 
recently developed a targatable uitrasonio contrast agent (nongaseous, bi- 
otinylated lipid encapsulated perftuoroceeban emulsion, moan particle size 
250 nm) that permits noninvasive detection of fibdn clots by binding to molec- 
ular ligands associated with thrombi and enhancing acoustic rallectivity. The 
targeted ultrasonic ontrast agent was prepared by biotinylating the fluorocar- 
bon emulsion particles. To mimic small, suspended, ameslinked fibrin thrombi, 
D-dimer was coated directly onto 0.8/~ palystyreno beads and ultrasonically 
imaged w,'th a 7.5 MHz linear phased army before and after eR)osure to the 
ligand-tergeted contrast agent. The polystyrene particles appeared opaque 
within dialysis tubing but manifested little ultrasonic backscefter. Sequen- 
tial addition of a biotinylaled monocional F(~) fragment directedagainst the 
D-dimer epRope 3B6, followed by aviclin, followed by biotinylated acoustic 
contrast rapidly increased the echogeniolty of the suspension. To mimic sur- 
face adherent, crossiinked flbdn thrombus, D-direst was covalently bound 
to nilrocelluluse membranes and ultrasonic imaging was performed before 
and after targeting with the parfluorocarbon emulsion with a high resolution, 
broadband 50 MHz acoustic microscope. The targeted ultrasonic ontrast in- 
creased the backscatter of the nitrocellulose membranes at all frequendes 
between 50 and 60 MHz, by an average 4.6 4- 0.1 dB (p < 0.05) above con- 
trois (2.9 fold enhancement). These results demonstrate th~ potential of this 
novel, site-targeted pertluorocarbon ultrasonic ontrast agent o specifically 
bind to molecular epitopes in fibdn clots, enhance their acoustic reflectlvity, 
and suggest a clinical role for clot detection with the use of ultrasound. 
~ Io Five-Year Morlality by Different for  Treatment 
Choice vs. Random Assignment In the Bypass 
Angioplasty Revasculadzstlon Invssti~atlan 
(BARI)? 
Katherine Detre, Nlan Rosen, Robert Jones, William Rogers, Michael Mock, 
David Faxon, Martial Bourasse, Frodedck Feit, Michael Cowley, Floy~ Loop 
aqd the BARI Investigators. University of Pittsburgh, Pittsburgh, PA 
BARI recruited 4110 patients with multivessal coronary artery disease mqt~ir- 
ing revascularlzation who were suitable for either CABG or PTCA. Consent 
for random treatment assignment was obtained from 1829 patients; another 
2013 preselVed the right to chose their treatment but agreed to be fogowed 
in a registry, and 268 refused to participate. W'dhin 3 months of study enW, 
CABG was the initial procedure for 32% of registry patients, PTCA for 58%, 
and the remaining 10% were maintained on medication only. 
Tx by Random Assignment Tx by Choice 
Age > 65 39% 40% 
Female 27% 26% 
African American 6% 4% 
Post HS Education 29% 40% 
Pmx/MId LAD 76% 69% 
# Lesion • 50% 3.1 3.0 
% Myocardium Jeopardized 61.1 59.2 
Hx MI 55% 51% 
Hx CHF 0% 5% 
Unstable Angina 64% 61% 
The 5-year mortality for patients in the BARI trial will be compared to the 
BARI registry adjusting for differences in patient charactodstics between the 
groups. 
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~ N e w  Ganeti© Coronary Artery Risk Factors for  
Disease 
Madsa Serrato, Qun-Tao Yu, Feye Safavi, Robert Roberts, All J. Marian. 
Baylor College of I~dicine, Houston, Texas 
Coronary artery disease (CAD) is a complex lrait caused by a number of ge- 
netic and environmental factors. Techniques of molecular genetics provide 
the opportunity to identify genes that may confer increased susceptibility 
for CAD. Human pareoxoneae/arylesterase (HUMPONA), involved in oxi- 
dation of LDL cholesterol, ~-fibdnogen, necessary for thrombosis, and the 
rantn angiotenaln system (anglotensinogan (AGT), angiotensin II receptor I
(ATIIRla)), which induces cell proliferation, are all involved in athemsclero- 
sis. Variants of these genes am known to encode for proteins that enhance 
their raspective function and am, thus, potential candidate genes for al- 
tered susceptibility to atherosclerosis. Thus, we determined the frequency 
of these variants in a genetically homogenous population with angiographi- 
celly documented CAD and in a comparable group in the general population. 
DNA was extracted from the blood and ganotyges were determined by poly- 
merase chain reaction, gel electrophoreais and/or mstricUon mapping. The 
two variants of AGT (M235T, T174M) and that of ATilRla exhibited asimilar 
frequency in both groups, while that of HUMPONA (G92A) and p-fibdnogen 
(G/A "4ss) showed increased frequency in the group with CAD as shown in 
the Table. 
Genotypes Control CAD Odds Ratio P value 
HUMPONA (GgP.A) 
/VA 120 (49%) 68 (30%) 2.2 (1.5-3.1) <0.CO01 
A/G + G/G 127(51%) 15S (70%) 
p Fibdnogen (G/A "4ss) 
G/G 153 (54%) 135 (75%) 2.5 (1.7-3.8) <0.0001 
G/A+/VA - 130(46%) 46(25%) 
The protein product of the HUMPONAgena variant is known to increase the 
rate of oxidation of LDL cholesterol several-fold and the p-fibdnogen variant 
is known to be associated with increased plasma levels of fibdnogen, both of 
which provide a rationale for increased risk of CAD and coronmy thrombosis. 
Identification and characterization fnonconventional genetic dsk factors for 
CAD will provide not only insight into the pathogenesis of athersclerosis but 
also dsk stmtif'cation for improved prevention and tmatmanL 
~ Circulating Correlates W'dh the Extent of VCAM-1 
Human Atherosclerosis, in Contrast to Circulating 
ICAM-1, E-selactin and Thrombomodulin 
Karlhei,'lz Peter, Peter Nawroth, Wolfram SchLsf, Thomas Nordt, 
Thomas Weiss, Christoph Bode. University of Heidelberg, Germany 
Secondary prevention of alheroealerosis, pdor to causing clinical symptoms, 
could be poss~e with a serum marker for atherosclerosis. Circulating, shed- 
dad forms of adhesion molecules may sere as such, since the cell surface 
expression of adhesion molecules is upragulated on endothelial cells cover- 
ing ab'~roscierotic plaques. In 52 patients with peripheral artedal vascular 
disease the extent of atherosclemsis was evaluated based on angiograms 
of a large par,on of the arterial system (the abdominal aorta, the pelvic and 
lag artadas). The area diseased by atheroscleresis was determined by the 
percentage of vessel wall irregularities of the calculated segments (total: 250 
cng). 
The serum concentration of circulating VCAM-1 demonstrates a strong 
correlation to the extent of atheroscierosis (r= 0.8, p < 0.001, y = 7.3x ng/ml 
cm -2 + 294 ng/ml), in contrast o circulating ICAM-1, E-selectin, or throm- 
bomodulin (as a marker for endothelial cell damage). The angiogrsphically 
evaluated patients were ~ in a group with minor (n = 30, area < 90 cn~) 
and a group with major atharesclerotic changes (n = 22, area > 90 cm2). The 
serum level of circulating VCAM-1 allows to separate these two stages of 
atharesclerosas with a high st:itistical significance (623 + 157 ng/ml versus 
1238:1:528 ngtml, p < 0.001). 
Condus/ons: Circulating VCAM-1 demanstmtes a strong correlation to 
the extent of human atherosclerosis. Whether patients who will profit from 
agreasive diagnosis and troalment can be identified by increased levels of 
circulating VCAM-1 remains to be proven. 
~ Prssence and Distribution of Vascular Wall 
Adrenomedullln in Experimental Atherosclarosla 
Eric E. Williamson, Michihisa Jougasaki, Iftikher Kugo, John C. Bumeft Jr.. 
Mayo Clinic, Rochester, MN 
Adrenomedugin (ADM) is a newly discovered potent vasorelaxant peptide, 
recently demonstrated tobe synthesized by cuitured endothelial end vascu- 
lar smooth muscle coils. Although ADM may function as an autocdne and 
paracdne factor in cardmvascular homeostasis, its activity in disease states 
such as atheroscierosis has not been defined. The present study was per- 
formed to determine the presence and distribution of ADM in normal and 
atherosclemtio rabbit aorta by imruunohistechemistry utilizing a highly spe- 
cific antg0edy to rabbit ADM. Studies were designed to test the hypothesis that 
ADM is present in normal aortic endothelial nd vascular smooth muscle ceils 
and is increased in atherosclerosis nresponse to vascular wall injury. To test 
this hypothesis, aortic tissue was obtained from normal (n -- 4) and cholesterol 
fed rebi)its (n = 14) (1% cholesterol diet for 8-10 weeks). In normal coutxo| 
~F 
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rabbits, Intense bands of positive immunostalning for ADM was obsewed in 
the endothelial and immediate subendothellal regions, with minimal staining 
In underlying vascular smooth muscle. In contrast, the atherosclerotic aortas 
• demonstrated positive immunostalning in the vascular smooth muscle as 
well as in the atherosclarotic plaque, with a loss of endothelial staining in 
damaged ~ndothellum. The current study demonstrates for the flint time the 
presevme of immunoreactive ADM in the normal endothalium. Secondly, the 
studies also demonstrate the loss of endo'helial ADM immunoreaciivity in 
stbercsclerosis with markedly increased activity in the atherosclerotic plaque 
and undedying vascular smooth muscle in hypercholesterolerclc atheroscle- 
rosls. These studies support an important role for ADM in cardiovascular 
regulation and its potential aslivetlon in experimental therosclarosis, 
~ Polymorphisms in the Angiotensln I-Converting 
Enzyme and Apolipoprsfain E Genes and Late 
Luminal Narrowing After Coronary Angioplssty In 
Men 
Christian Moussard, Alaln Vuillemenot, Fmnqois Schieta, 
Nicolas Moneveau, Jean,Claude Henry, Jean-Pierre Bassand. University 
Hospital Resangon, FRANCE 
Poly..loqohisms in the angiotensin I-converting enzyme gane (ACE I/D} and 
upolipoprotoln E (ape E) may be I~nked to coronary heart disease, with re- 
spactively alleles D and e4 as dsk factor. Therefore we investigated the 
relationship between the ACt= I/D and upo E genatypes and the incidence 
of restenosls after coronary angiuptasty. Methods. Amplification of genomic 
DNA using polymerese chain reaction (PCR) and restriction enzyme frag- 
ment length polymorphisms (RFLP) yielded the ACE genotypos II, ID and 
DD, and Ape E ganotypas (e2e3, e3e3, e2e4, a3e4 and e4e4) in 91 male 
patients with CAD. Results. The frequency of the DD genotype was signifi- 
cantly higher among CAD patients than controls (38/91 = 0.42 versus3511~J 
= 0.29, p = 0.05). No significant difference in DD genotype frequency was 
found between patients with restenosls (defined as • 50% diameter alenesis 
at 6 months fcilow-up) and patients without restenosis (18/37 = 0.49 versus 
20/54 = 0.37, p = 0.27). Nevertheless D allele relative frequency was higher 
in pstients With restenosis (0.Tq versus 0.59, P = 0.09). The mean differ- 
ence in minimal coronary lume, diameter between post-PTCA and follow-up 
angiogram (late Io~) was no significantly different in the 3 groups of ACE 
genotypa. The relative e4 allele frequency was higher among CAD patients 
than controls (0.16 versus 0.10, p = 0.05). The distributions of ape E gano- 
types or alleles in restenosis group was not significantly different from that 
of the ncn-restenosls group. Late loss was similar in patient with or without 
allele e4 in their genotype. In conclusion, Pclymoqohlsm In the angiatensin 
I-converting enzyme and apolipoprotein E genes had no influence on the 
occursnca of restenosis after coronary ecgioplasty. 
D Polymorphism ot the Anglotensln Convert ing 
Enzyme Gene Is Strongly ASsociated Wllh the 
Development of  Physiological Left Ventricular 
Hypertrophy 
Hugh Montgomery, Peter Ctarkson, Clare Dollery, Krishna Prosed, 
Made-Angola Losl, Deborah Stattere, Mick Jubb 1, Jean McEwan, 
Stephen Humphdes, William McKenca. UCL and St George's Medical 
Schools, London, UK; ~ RAMC Mi//bank, London, UK 
The I/D polymorphlsm of the anglotsnsln-conveding enzyme (ACE) gene 
comprises the presence (insertion allele, I) or absence (deletion allele, D) 
of a 297 base pair fragment. The D allele is associated with higher clr- 
culstlng (and possibly tissue) ACE levels. We tested the hypothesis that 
ranln-anglotsnsin systems control myocardial growth, by examining the influ- 
ence of ACE genolypa on physiological left ventr/cuMr hypertrophy. Method 
and Results: ACE genatypa was determined in 154 male British Army re- 
cmits. B.nstluretlc peptlde(BNP) levels (a hormone whose levels are linked 
to LV mass) and echooardlngraphlsally-determlned posterior wall(PW) and 
septet hickness (ST) and left ventdcular mass(LVM) were measured at the 
start and end of 10 weeks of intensive physical training. All measures of LV 
hypertrophy were associated strongly with the D allele (table shows changes 
in all parameters: p for heterogeneity < 0.001: < 0.08 t) 
I! ID DD 
ST (mm) -0.03 0.08 0.14" 
PW (mm) -0.03 0.08 0.13" 
LVM (g) -1.27 47.2 56.9" 
L ..Vl~Nheight (g/cm) -0.01 0.27 0.32* 
BNP levels ross by 40%, 64=/0 and 180% respectively (p < 0.01). 
Conclusions: Left ventricular growth in response to exercise is strongly 
determined by ACE ganotype. This finding has important implications con- 
cerning the rote of renln-angtotensln systems in pathuphyslologlcal LVH. 
Serum Autcenl lbodles Against  G-Protein 
Coupled Receptors In Myocardial  Diseases 
Shlnohu MatsuI, Michael Fu ~, Tomoyukl Hirakawa, Kohal Teranka, 
Mitanru Hayase, Noberu Takskashl, ElJi MurakamL Kanazawa Mad'col 
University, Japan; 1 C~teborg University,, Sweden 
There is an increasing evidence for the participation of cellular and humorel 
autoimmunlty in the pathngenasls of various myocardial ¢~isaeses. The pur- 
pose of this study was to assess the pathophysiotoglcal role of autoantibod- 
tes against G-preteln coupled receptors in myocarditis(MC), dilsted(DCM) 
One hypedrophic(HCM) cardlomyopathy. Five poptides corresponding to the 
sequences of the second extracellular loops of the human ~1-, 82, el ,  
mussadnic chdiinergtc(M,?.) and angtotensln-II(AII) receptors were used as 
antigens in an enzyme immunoassay to screen ~era from patients with MC(N 
= 18), DCM(n = 28), HCM(n = 23) and the age-matched healthy blood donor 
(HBD)(n = 23). 
[Results] Detection of autoantibodies by ELISA. 
~81 ,82 al M2 All 
DCM(n = 28) 9 (32%)** 2 (7%) 4 (14%) 10 (36%)" 1 {4%) 
MC(n= 18) 6(33%) "° 2(11%) 3(17%) 2(11%) 3(17%) 
HCM(n=23) 3(13%) 1 (4%) 2 (6%) 5(22%) 0 (0%) 
HBD(n-23) 2 (9%) 2 (6%) 2 (9%) 3(13%) 3(13%) 
""p .,: 0.05, "p < 0.1 vs. HBD 
[Conclusion] A subgroup of patients with DCM and mycoarditis have au- 
tcantibodias pecifically directed against the second ext~caltutar loops o! 
the ~1 and/or M2 receptors. These autoantibedies (anti-,at and anti M2) 
could play an important role in pathogenesis of myocard{tis and DCM. These 
findings also indicate that the evolution of DCM alter myoca~lls might be 
predominantly due to an autolmmune mechanism. 
~ Incrsased Frequency o f  the Deletion Allele of  the 
ACE Gene in Afr ican-Americans Compared to 
Caucasians 
Baxter D. Montgomery, Elizabeth A. Putnam, John Reveille, Dianna 
M. Mifewicz. The University of Texas Health Science Center at Houston, TX 
The inse:tion/daletion (I/D) DNA polymorphlsm of the anglatensln converting 
enzy~,o (ACE) gone has been studied in patients with heart disease. The 
DD ganotypo has been found to be associated with increased left ventricutar 
mass (LVM) independent of syststlc or diastolic blood pressure (BP). African- 
Ameflcans have more left vantricular hypertrophy (LVH) than Cs,.~casPane with 
equivalent BR The D allele has been found at a frequency of approximately 
50% in studies of Caucasian populations. We compared the frequency of the 
D allele in the above populations. We hypothesize that the frequency of the 
D allele will be increased among Afdcan-Americans(AA) as it may explain 
a genetic contribution to the increase frequency of LVH among African. 
Americans. Methods: Genomic DNA was harvested from peripheral blood 
leukocytes obtained from 29 unrelated, healthy Affican-Amarlcans and 29 
Caucasians. The gonatypo f the ACE gone was determined b.v DCR using 
the ganomic DNA samples and standard pdmers and condition~. 
Results: 
Populations I allele (%) D allele (%) p value 
AA 15 (26%) 43 (14%) .,:0.05 
Caucasians 27 (47%) 31 (52%) 
Conclusions: The frequency of the D allele Is significantly increased In 
the population of Afdcan-Ameticans compared to Caucasians. These data 
suggest that a possible genellc contribution to the increased incidence of 
LVH found in the population of AfdcanoAmedcans. 
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~ C o s t  Avoidance Through Early Discharge of  the 
Uncomplicated Acute Myocardial  Infarction Patient 
Eric L. Elsensteln, L Kflstin Newby, J. David Knight, Leslee J. Shaw, Robed 
M. Catiff, Eric J. Topoi, Daniel B. Mark. Duke University Medical Center, 
Durham, NC 
Analysis of GUSTO-I data has shown that uncomplicated acute myocardial 
infarction (UCMI) patients (without ralnfarctlon, ischemta, stroke, shock, head 
